Work

To Market, to Market–2022: Small Molecules

Year: 2023

Type: book-chapter

Source: Medicinal chemistry reviews

DOI: 10.1021/mc-2023-vol58.ch24

Authors: Erika Araujo, Ian M. Bell, Alexander Burckle, Dennis C. Koester, James R. Manning, Georgette Castanedo, Mingshuo Zeng, T. G. Murali Dhar, Natalie Holmberg-Douglas, Eric R. Welin, J. Robert Merritt, Kevin M. Peese, Joanne J. Bronson

Institutions: Arvinas (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), Gilead Sciences (United States), FibroGen (United States), Genentech, Bristol-Myers Squibb (United States), Connecticut Science Center

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

Open Access status: closed

OpenAlex ID: W4388733685

FWCI: 1.881

Cites: 190

Cited by: 4

Related to: 10